Sevene

What Sevene does

Sevene SAS is a privately held French pharmaceutical company founded in 2001 by Damien Verrier (CEO) and Guillaume Loïs, headquartered in Saint-Hippolyte-du-Fort in the Cévennes region of southern France. The company operates a vertically integrated natural-health value chain spanning the cultivation of organic medicinal plants on its 70-hectare ECOCERT-certified Mazet estate, production of mother tinctures and homeopathic remedies in a GMP-certified pharmaceutical laboratory, and commercialization under multiple brands. Its proprietary technology includes a natural slow drying process for mother tinctures that preserves active ingredients, and a range of 15 low-dilution homeopathic medicines (each derived from three complementary plants and covering five physio-metabolic systems), of which 9 carry French marketing authorization (AMM).

Sevene commercializes through two distinct go-to-market motions. In France, the company produces and sells its medicinal plants, mother tinctures, and 15-medicine range directly through its pharmaceutical laboratory. In the United States, where it operates a wholly owned subsidiary (Sevene USA / HBC Naturals / Olloïs) based in Pacoima, California, the company distributes the Olloïs brand of 45 single homeopathic remedies and 14 Ollopets veterinary remedies through the country's largest specialist Natural Health retail networks, supplemented by direct-to-consumer e-commerce via olloïs.com. Beyond branded sales, Sevene provides contract manufacturing services through its GMP production unit to industrial and commercial partners, and is developing agro-homeopathy solutions for viticulture under its HomeoVigne program.

The company's revenue model combines branded product sales (one-off transactions through retail and e-commerce channels), third-party B2B manufacturing services, and sales of high-quality raw materials (medicinal plants and mother tinctures) following HAB (German) and HPUS (US) pharmacopoeia standards. Pricing is not publicly disclosed. The company is managed through Stormrider Management SARL, has no disclosed external investors, and its legal share capital is €758,893.20. Headcount is reported at 11–50 employees.

Name

Sevene

Legal name

Sevene SAS

Website

https://sevene-group.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Sevene SAS is a French pharmaceutical company that vertically integrates organic medicinal plant cultivation, GMP-certified mother tincture production, and homeopathic medicine manufacturing, selling 15 proprietary medicines in France and the Olloïs brand of 45+ single remedies in the US through Natural Health retail networks.

Ownership category

akta.pro rank

Product category

Homeopathic Pharmaceuticals

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)

akta.pro secondary industries

Organic Herb, Spice & Medicinal/Aromatic Plant Farming (AFAGAKAE), Compounding Pharmacies (Veterinary) (HLAMAIAD), Botanical Biopesticides & Plant Extracts (Essential Oils, Neem, Pyrethrins) (AFABAEAF)

Keywords

• Homeopathic medicines
• Medicinal plant cultivation
• Mother tinctures
• Natural health products
• Plant-based remedies

Headquarters

HQ city

Saint-hippolyte-du-fort

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Homeopathic Remedies - Olloïs Brand: Sevene produces and commercializes its Olloïs brand of homeopathic remedies in the USA through specialist Natural Health retail networks. Includes 45 single remedies in tube-packed pellets and 14 veterinary remedies (Ollopets) for dogs and cats.
2. Industrial and Commercial Partner Production: GMP production unit manufactures third-party products under industrial and commercial partnerships, providing manufacturing services to other companies.
3. Medicinal Plants and Mother Tinctures: Sale of high-quality medicinal plants and mother tinctures for phytotherapy and homeopathy production, following HAB and HPUS pharmacopoeias.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Sevene cultivates medicinal plants on its ECOCERT-certified 70-hectare Mazet estate in the Cévennes region and, in its GMP-certified French pharmaceutical laboratory, transforms them into mother tinctures and homeopathic medicines under HAB and HPUS pharmacopoeias. It sells the Olloïs brand of single homeopathic remedies and Ollopets veterinary line through US natural-health retail networks and direct e-commerce, and offers contract GMP manufacturing and bulk medicinal-plant and tincture sales to industrial partners.

Product overview

Sevene is a vertically integrated natural health company that operates across two continents (France and USA) with a comprehensive product portfolio spanning medicinal plants, mother tinctures, and homeopathic remedies. In France, the company cultivates medicinal plants at its ECOCERT-certified Mazet estate in the Cévennes and produces pharmaceutical-grade mother tinctures and homeopathic medicines in its GMP-certified laboratory. Sevene has developed 15 homeopathic medicines (9 with French marketing authorization) covering five physio-metabolic systems. In the USA, the company markets the Olloïs brand of homeopathic remedies (45 single remedies plus 14 Ollopets veterinary products) through natural health retail networks. Additionally, Sevene is pioneering agro-homeopathy solutions for viticulture through its HomeoVigne program. The company also offers third-party manufacturing services through its GMP production facilities.

Differentiator

Problem solved

Functional benefit

Brands

• Olloïs: Homeopathic remedies brand marketed and sold in the USA market, featuring 45 single remedies in tube-packed pellet form covering a wide spectrum of ailments.
• Ollopets
• HBC Naturals

Quantifiable outcome

• 15 medicines developed covering 5 physio-metabolic systems
• +2 more outcomes

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• CNRS (French National Centre for Scientific Research)coreStrategic or Co-development PartnerResearch partnership with CNRS confirmed the extremely high quality and purity of soil and water at the Mazet estate in the Cévennes region, supporting Sevene's organic medicinal plant cultivation program.
• Scientific team and winegrowers (Agro-Homeopathy)coreStrategic or Co-development PartnerPartnership with scientific researchers and winegrowers to develop agro-homeopathy solutions for vineyard management. Combines experimentation with fundamental research to develop natural treatments for vines and soil.
• Industrial and Commercial PartnersminorChannel Partner/ Reseller/ DistributorThird-party manufacturing partnerships using Sevene's GMP-certified production unit for homeopathic products.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hyland's (Standard Homeopathic Company): US-based homeopathic OTC brand with broad retail distribution, directly competing with Olloïs in American natural health channels. One of the principal single-remedy and combination-remedy competitors in Sevene's largest international market.
• Biologische Heilmittel Heel: German homeopathic pharmaceutical company producing combination homeopathic remedies under GMP. Comparable to Sevene in manufacturing approach, combination-remedy development methodology, and presence in regulated European markets.
• Washington Homeopathic Products: US single-remedy homeopathic manufacturer producing HPUS-compliant remedies for retail and practitioner channels. A direct manufacturing comparable, especially relevant to Sevene's Olloïs single-remedy line.
• Homeocan: Canadian homeopathic manufacturer producing single remedies and combination products in HPUS-compliant formats. Comparable as a North American single-remedy competitor with overlapping retail and pharmacy distribution.
• Nelsons: UK heritage homeopathic manufacturer producing single remedies under HPUS and the Bach flower remedy line. Comparable as a single-remedy producer following HPUS pharmacopoeia standards with both retail and DTC channels.
• Boiron: Global leader in homeopathic medicines, headquartered in France, with the broadest single-remedy and specialty product portfolio worldwide. Boiron is the most directly comparable competitor across both Sevene's French franchise and Olloïs's US single-remedies market.
• Hahnemann Laboratories: California-based homeopathic manufacturer producing single remedies and combination products under HPUS. A direct West-Coast US competitor to Olloïs with overlapping practitioner and retail distribution.
• Deutsche Homöopathie-Union (Schwabe Group): German homeopathic manufacturer and part of the Dr. Willmar Schwabe Group, producing single remedies under HAB pharmacopoeia — the same standard Sevene follows. A direct manufacturing and pharmacopoeia-compliance peer.

Broad incumbents

• Martin Bauer Group: Global supplier of botanical extracts, teas, and plant-based ingredients for pharmaceutical and nutraceutical applications. Comparable to Sevene's mother tincture and medicinal-plant operations at the upstream ingredient-manufacturing level, though operating at much greater scale.
• Indena: Italian global leader in identification, development, and production of botanical active ingredients for the pharmaceutical and nutraceutical industries. Comparable as a high-purity medicinal plant extract supplier — relevant to Sevene's mother tincture operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/sevenepharma

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sevene